KETAMINE Treatment Philadelphia
IV ketamine therapy is a revolutionary therapeutic approach to treating depression and anxiety disorders. Ketamine therapy is significantly more effective than all other pharmaceuticals, is very safe, and has no side effects. It is usually life-changing.
Several scientific studies, including those conducted at Yale University and the National Institute of Mental Health, have shown that low dose intravenously administered ketamine can dramatically improve symptoms associated with depression and many anxiety disorders. Often, even when other treatments have failed to provide any relief, IV ketamine is effective.
All new patients have a series of six infusions spaced over two or three weeks. Each infusion is 40 minutes long, painless, and well tolerated. Most patients experience significant relief during the series and many remain symptom free for extended periods of time following the initial treatment protocol.
Ketamine therapy impacts both mood and anxiety disorders with positive treatment outcomes for the following diagnoses:
Depression, Chronic Depression, and Treatment Resistant Depression
Post Traumatic Stress Disorder (PTSD)
Obsessive Compulsive Disorder (OCD)
Post Partum Depression
Many Anxiety Disorders
Call now to Make an Appointment
John Applegate, MD & Associates has been providing the highest quality, cutting-edge psychiatric care to the Philadelphia area for over 15 years. Dr. Applegate is a board-certified adult psychiatrist and is on staff in the Psychiatry Department at the Hospital of the University of Pennsylvania. Dr. Applegate graduated medical school from the Rutgers New Jersey Medical school and completed his residency in psychiatry at the University of Pennsylvania. Because Dr. Applegate is referred some of the most complex cases he has extensive experience providing effective and innovative treatment options, even when his patients have not had success with many traditional approaches. He is also able to evaluate for and provide other neuromodulation techniques, such as TMS, tDCS, and is planning to incorporate other psychedelic treatment options as they become established and safe. He is able to improve patient outcomes by considering a combination of these treatments when indicated. He specializes in bipolar disorder, treatment-resistant depression, various anxiety disorders, OCD, and PTSD.